SCHEMBL16409482

SCHEMBL16409482

CC/C=C\CNCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2759566 1.00
Hydrochloric Acid SCHEMBL22575365 0.97
Hydrochloric Acid SCHEMBL22575364 0.97
SCHEMBL562702 0.90 KDM1A (0.63)
SCHEMBL562701 0.90 KDM1A (0.63)
SCHEMBL12951512 0.87 KDM1A (0.60)
SCHEMBL428790 0.87 KDM1A (0.46)
SCHEMBL12082977 0.87 KDM1A (0.60)
SCHEMBL428791 0.87 KDM1A (0.46)
SCHEMBL13624704 0.85 KDM1A (0.71)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3191483-B1 COMPOUNDS AS CRTH2 ANTAGONIST AND USES THEREOF NORTH & SOUTH BROTHER PHARMACY INVESTMENT CO LTD (CN) 2020-06-10 EP disclosed
WO-2014195919-A1 ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2014-12-11 WO disclosed